A novel theranostic nanoplatform for imaging-guided chemo-photothermal therapy in oral squamous cell carcinoma-Reference-Cited by-同舟云学术

A novel theranostic nanoplatform for imaging-guided chemo-photothermal therapy in oral squamous cell carcinoma

Published:2021 Issue:30 Volume:9 Page:6006-6016
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Gu Mengqin¹²³⁴⁵^ORCID,Jiang Li¹²³⁴⁵,Hao Liying¹²³⁴⁵,Lu Junzhuo¹²³⁴⁵,Liu Zhenqi¹²³⁴⁵,Lei Zixue¹²³⁴⁵,Li Yijun¹²³⁴⁵,Hua Chengge⁶²³⁴⁵,Li Wei¹²³⁴⁵,Li Xiyu¹²³⁴⁵^ORCID

Affiliation:

1. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases

2. West China Hospital of Stomatology

3. Sichuan University

4. Chengdu

5. China

6. Department of General Dentistry

Abstract

We constructed the PDA-modified HATb nanoparticle encapsulating the anticancer drug DOX (HATb-PDA-DOX), which achieved pH/NIR triggered drug release and imaging-guided synergistic chemo-photothermal tumor therapy.

Funder

National Natural Science Foundation of China

Sichuan University

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2021/TB/D1TB01136G

Reference33 articles.

1. Peptide functionalized upconversion/NIR II luminescent nanoparticles for targeted imaging and therapy of oral squamous cell carcinoma

2. Periodic Oxaliplatin Administration in Synergy with PER2‐Mediated PCNA Transcription Repression Promotes Chronochemotherapeutic Efficacy of OSCC